-
1
-
-
67349227863
-
Treatment of chronic constipation: Current pharmacologic approaches and future directions
-
J. Tack, and S. Müller-Lissner Treatment of chronic constipation: current pharmacologic approaches and future directions Clin Gastroenterol Hepatol 7 5 2009 May 502 508
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, Issue.5
, pp. 502-508
-
-
Tack, J.1
Müller-Lissner, S.2
-
2
-
-
33646201684
-
Functional bowel disorders
-
G.F. Longstreth, W.G. Thompson, W.D. Chey, L.A. Houghton, F. Mearin, and R.C. Spiller Functional bowel disorders Gastroenterology 130 5 2006 Apr 1480 1491
-
(2006)
Gastroenterology
, vol.130
, Issue.5
, pp. 1480-1491
-
-
Longstreth, G.F.1
Thompson, W.G.2
Chey, W.D.3
Houghton, L.A.4
Mearin, F.5
Spiller, R.C.6
-
3
-
-
0036766482
-
Self-prescribed laxative use: A drug-utilization review
-
G. Motola, F. Mazzeo, B. Rinaldi, A. Capuano, S. Rossi, and F. Russo Self-prescribed laxative use: a drug-utilization review Adv Ther 19 5 2002 Sep-Oct 203 208 (Pubitemid 36091331)
-
(2002)
Advances in Therapy
, vol.19
, Issue.5
, pp. 203-208
-
-
Motola, G.1
Mazzeo, F.2
Rinaldi, B.3
Capuano, A.4
Rossi, S.5
Russo, F.6
Vitelli, M.R.7
Rossi, F.8
Filippelli, A.9
-
4
-
-
79960420661
-
Diagnosis and treatment of chronic constipation - A European perspective
-
(in press)
-
Tack J, Muller-Lissner S, Stanghellini V, Boeckxstaens G, Kamm MA, Simren M, et al. Diagnosis and treatment of chronic constipation - a European perspective. Neurogastroenterology and Motility (in press).
-
Neurogastroenterology and Motility
-
-
Tack, J.1
Muller-Lissner, S.2
Stanghellini, V.3
Boeckxstaens, G.4
Kamm, M.A.5
Simren, M.6
-
5
-
-
17544361897
-
Efficacy and safety of traditional medical therapies for chronic constipation: Systematic review
-
DOI 10.1111/j.1572-0241.2005.40925.x
-
D. Ramkumar, and S.S. Rao Efficacy and safety of traditional medical therapies for chronic constipation: systematic review Am J Gastroenterol 100 4 2005 936 971 (Pubitemid 40592390)
-
(2005)
American Journal of Gastroenterology
, vol.100
, Issue.4
, pp. 936-971
-
-
Ramkumar, D.1
Rao, S.S.C.2
-
6
-
-
0031048696
-
The treatment of chronic constipation in adults: A systematic review
-
DOI 10.1007/s11606-006-0003-5
-
S. Tramonte, M. Brand, C. Mulrow, M. Amato, M. O'Keefe, and G. Ramirez The treatment of chronic constipation in adults: a systematic review J Gen Intern Med 12 1 1997 15 24 (Pubitemid 27114062)
-
(1997)
Journal of General Internal Medicine
, vol.12
, Issue.1
, pp. 15-24
-
-
Tramonte, S.M.1
Brand, M.B.2
Mulrow, C.D.3
Amato, M.G.4
O'Keefe, M.E.5
Ramirez, G.6
-
7
-
-
33846981109
-
Chronic constipation: A survey of the patient perspective
-
J. Johanson, and J. Kralstein Chronic constipation: a survey of the patient perspective Aliment Pharmacol Ther 25 5 2007 599 608
-
(2007)
Aliment Pharmacol Ther
, vol.25
, Issue.5
, pp. 599-608
-
-
Johanson, J.1
Kralstein, J.2
-
8
-
-
0025109518
-
Cost-effective treatment of constipation in the elderly: A randomized double-blind comparison of sorbitol and lactulose
-
DOI 10.1016/0002-9343(90)90177-F
-
F. Lederle, D. Busch, K. Mattox, M.J. West, and D.M. Aske Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose Am J Med 89 5 1990 597 601 (Pubitemid 20384316)
-
(1990)
American Journal of Medicine
, vol.89
, Issue.5
, pp. 597-601
-
-
Lederle, F.A.1
Busch, D.L.2
Mattox, K.M.3
West, M.J.4
Aske, D.M.5
-
10
-
-
0033967018
-
A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative
-
DOI 10.1016/S0002-9270(99)00824-2, PII S0002927099008242
-
J. Di Palma, P. DeRidder, R. Orlando, B. Kolts, and M. Cleveland A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative Am J Gastroenterol 95 2 2000 446 450 (Pubitemid 30106174)
-
(2000)
American Journal of Gastroenterology
, vol.95
, Issue.2
, pp. 446-450
-
-
Dipalma, J.A.1
Deridder, P.H.2
Orlando, R.C.3
Kolts, B.E.4
Cleveland, M.V.5
-
11
-
-
33847068622
-
An open-label study of chronic polyethylene glycol laxative use in chronic constipation
-
J.A. Di Palma, M.V. Cleveland, J. McGowan, and J.L. Herrera An open-label study of chronic polyethylene glycol laxative use in chronic constipation Aliment Pharmacol Ther 25 6 2007 Mar 15 703 708
-
(2007)
Aliment Pharmacol Ther
, vol.25
, Issue.6
, pp. 703-708
-
-
Di Palma, J.A.1
Cleveland, M.V.2
McGowan, J.3
Herrera, J.L.4
-
12
-
-
33745685698
-
Long-term efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: A retrospective study in a disabled population
-
DOI 10.1185/030079906X112543
-
I. Migeon-Duballet, M. Chabin, A. Gautier, T. Mistouflet, M. Bonnet, and J.M. Aubert Long-term efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: a retrospective study in a disabled population Curr Med Res Opin 22 6 2006 1227 1235 (Pubitemid 44000743)
-
(2006)
Current Medical Research and Opinion
, vol.22
, Issue.6
, pp. 1227-1235
-
-
Migeon-Duballet, I.1
Chabin, M.2
Gautier, A.3
Mistouflet, T.4
Bonnet, M.5
Aubert, J.M.6
Halphen, M.7
-
13
-
-
34548139322
-
A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation
-
DOI 10.1111/j.1572-0241.2007.01365.x
-
J. Di Palma, M. Cleveland, J. McGowan, and J. Herrera A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation Am J Gastroenterol 102 2007 1964 1971 (Pubitemid 47301532)
-
(2007)
American Journal of Gastroenterology
, vol.102
, Issue.9
, pp. 1964-1971
-
-
Di Palma, J.A.1
Cleveland, M.V.B.2
McGowan, J.3
Herrera, J.L.4
-
17
-
-
33748423741
-
A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence
-
DOI 10.1542/peds.2006-0220
-
V. Loening-Baucke, and D. Pashankar A randomized, prospective, comparison study of Polyethylene Glycol 3350 without electrolytes and Milk of Magnesia for children with constipation and fecal incontinence Pediatrics 118 2006 528 535 (Pubitemid 46085407)
-
(2006)
Pediatrics
, vol.118
, Issue.2
, pp. 528-535
-
-
Loening-Baucke, V.1
Pashankar, D.S.2
-
18
-
-
0030017625
-
Exogenous lipid pneumonia: A retrospective multicentre study of 44 cases in France
-
DOI 10.1183/09031936.96.09071463
-
A. Gondouin, P. Manzoni, E. Ranfaing, J. Brun, J. Cadranel, and D. Sadoun Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France Eur Respir J 9 7 1996 Jul 1463 1469 (Pubitemid 26233791)
-
(1996)
European Respiratory Journal
, vol.9
, Issue.7
, pp. 1463-1469
-
-
Gondouin, A.1
Manzoni, Ph.2
Ranfaing, E.3
Brun, J.4
Cadranel, J.5
Sadoun, D.6
Cordier, J.F.7
Depierre, A.8
Dalphin, U.C.9
-
19
-
-
0027422273
-
Effects of 'contact laxatives' on intestinal and colonic epithelial cell proliferation
-
K. Geboes, G. Nijs, U. Mengs, K.P. Geboes, A. Van Damme, and P. de Witte Effects of 'contact laxatives' on intestinal and colonic epithelial cell proliferation Pharmacology 47 Suppl. 1 1993 Oct 187 195 (Pubitemid 23291031)
-
(1993)
Pharmacology
, vol.47
, Issue.SUPPL. 1
, pp. 187-195
-
-
Geboes, K.1
Nijs, G.2
Mengs, U.3
Geboes, K.P.J.4
Van Damme, A.5
De Witte, P.6
-
20
-
-
77950519743
-
Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation
-
S. Mueller-Lissner, M.A. Kamm, A. Wald, U. Hinkel, U. Koehler, and E. Richter Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation Am J Gastroenterol 105 4 2010 Apr 897 903
-
(2010)
Am J Gastroenterol
, vol.105
, Issue.4
, pp. 897-903
-
-
Mueller-Lissner, S.1
Kamm, M.A.2
Wald, A.3
Hinkel, U.4
Koehler, U.5
Richter, E.6
-
21
-
-
34247370973
-
Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation
-
DOI 10.1185/030079907X178865
-
S. Kienzle-Horn, J.M. Vix, C. Schuijt, H. Peil, C.C. Jordan, and M.A. Kamm Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation Curr Med Res Opin 23 4 2007 691 699 (Pubitemid 46631472)
-
(2007)
Current Medical Research and Opinion
, vol.23
, Issue.4
, pp. 691-699
-
-
Kienzle-Horn, S.1
Vix, J.-M.2
Schuijt, C.3
Peil, H.4
Jordan, C.C.5
Kamm, M.A.6
-
22
-
-
33846347644
-
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
-
DOI 10.1053/j.gastro.2006.11.002, PII S001650850602436X
-
M.D. Gershon, and J. Tack The serotonin signaling system: from basic understanding to drug development for functional GI disorders Gastroenterology 132 1 2007 Jan 397 414 (Pubitemid 46127672)
-
(2007)
Gastroenterology
, vol.132
, Issue.1
, pp. 397-414
-
-
Gershon, M.D.1
Tack, J.2
-
23
-
-
79952386049
-
-
Submitted for publication
-
Tack J, Camilleri M, Chang L, Chey W, Galligan JJ, Lacy BE, et al. Systematic review of cardiovascular safety profile of 5-HT4 agonists developed for GI disorders. [Submitted for publication].
-
Systematic Review of Cardiovascular Safety Profile of 5-HT4 Agonists Developed for GI Disorders
-
-
Tack, J.1
Camilleri, M.2
Chang, L.3
Chey, W.4
Galligan, J.J.5
Lacy, B.E.6
-
24
-
-
0033258353
-
Cardiac adverse effects of gastrointestinal prokinetics
-
DOI 10.1046/j.1365-2036.1999.00655.x
-
M. Tonini, F. de Ponti, A. di Nucci, and F. Crema Review article: cardiac adverse effects of gastrointestinal prokinetics Aliment Pharmacol Ther 13 1999 1585 1591 (Pubitemid 30009075)
-
(1999)
Alimentary Pharmacology and Therapeutics
, vol.13
, Issue.12
, pp. 1585-1591
-
-
Tonini, M.1
De Ponti, F.2
Di Nucci, A.3
Crema, F.4
-
25
-
-
77958452881
-
Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation
-
B. Al-Judaibi, N. Chande, and J. Gregor Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation Can J Clin Pharmacol 17 1 2010 Winter e194 e200
-
(2010)
Can J Clin Pharmacol
, vol.17
, Issue.1
-
-
Al-Judaibi, B.1
Chande, N.2
Gregor, J.3
-
27
-
-
0033005188
-
4 agonist, prucalopride, in healthy humans
-
E.P. Bouras, M. Camilleri, D.D. Burton, and S. McKinzie Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans Gut 44 5 1999 682 686 (Pubitemid 29195916)
-
(1999)
Gut
, vol.44
, Issue.5
, pp. 682-686
-
-
Bouras, E.P.1
Camilleri, M.2
Burton, D.D.3
McKinzie, S.4
-
28
-
-
0035121508
-
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder
-
E.P. Bouras, M. Camilleri, D.D. Burton, G. Thomforde, S. McKinzie, and A.R. Zinsmeister Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder Gastroenterology 120 2 2001 354 360 (Pubitemid 32147632)
-
(2001)
Gastroenterology
, vol.120
, Issue.2
, pp. 354-360
-
-
Bouras, E.P.1
Camilleri, M.2
Burton, D.D.3
Thomforde, G.4
McKinzie, S.5
Zinsmeister, A.R.6
-
29
-
-
44349130441
-
A placebo-controlled trial of prucalopride for severe chronic constipation
-
DOI 10.1056/NEJMoa0800670
-
M. Camilleri, R. Kerstens, A. Rykx, and L. Vandeplassche A placebo-controlled trial of prucalopride for severe chronic constipation N Engl J Med 358 2008 2344 2354 (Pubitemid 351749158)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.22
, pp. 2344-2354
-
-
Camilleri, M.1
Kerstens, R.2
Rykx, A.3
Vandeplassche, L.4
-
30
-
-
58149084950
-
Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation-a 12-week, randomized, double-blind, placebo-controlled study
-
E.M. Quigley, L. Vandeplassche, R. Kerstens, and J. Ausma Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation-a 12-week, randomized, double-blind, placebo-controlled study Aliment Pharmacol Ther 29 2009 315 328
-
(2009)
Aliment Pharmacol Ther
, vol.29
, pp. 315-328
-
-
Quigley, E.M.1
Vandeplassche, L.2
Kerstens, R.3
Ausma, J.4
-
31
-
-
61649119045
-
Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
-
J. Tack, M. van Outryve, G. Beyens, R. Kerstens, and L. Vandeplassche Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives Gut 58 2009 357 365
-
(2009)
Gut
, vol.58
, pp. 357-365
-
-
Tack, J.1
Van Outryve, M.2
Beyens, G.3
Kerstens, R.4
Vandeplassche, L.5
-
32
-
-
72049090263
-
Safety assessment of prucalopride in elderly patients with constipation: A double-blind, placebo-controlled study
-
M. Camilleri, G. Beyens, R. Kerstens, P. Robinson, and L. Vandeplassche Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study Neurogastroenterol Motil 21 12 2009 Dec p. 1256-e117
-
(2009)
Neurogastroenterol Motil
, vol.21
, Issue.12
-
-
Camilleri, M.1
Beyens, G.2
Kerstens, R.3
Robinson, P.4
Vandeplassche, L.5
-
33
-
-
77955493094
-
A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation
-
S. Müller-Lissner, A. Rykx, R. Kerstens, and L. Vandeplassche A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation Neurogastroenterol Motil 22 9 2010 Sep 991 998 e255
-
(2010)
Neurogastroenterol Motil
, vol.22
, Issue.9
, pp. 991-998
-
-
Müller-Lissner, S.1
Rykx, A.2
Kerstens, R.3
Vandeplassche, L.4
-
34
-
-
72449143707
-
Effects of velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation
-
M.L. Manini, M. Camilleri, M. Goldberg, S. Sweetser, S. McKinzie, and D. Burton Effects of velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation Neurogastroenterol Motil 22 1 2010 Jan 42 49 e7-e8
-
(2010)
Neurogastroenterol Motil
, vol.22
, Issue.1
, pp. 42-49
-
-
Manini, M.L.1
Camilleri, M.2
Goldberg, M.3
Sweetser, S.4
McKinzie, S.5
Burton, D.6
-
35
-
-
78649489728
-
Clinical trial: The efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - A 4-week, randomized, double-blind, placebo-controlled, dose-response study
-
M. Goldberg, Y.P. Li, J.F. Johanson, A.W. Mangel, M. Kitt, and D.T. Beattie Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study Aliment Pharmacol Ther 32 9 2010 Nov 1102 1112
-
(2010)
Aliment Pharmacol Ther
, vol.32
, Issue.9
, pp. 1102-1112
-
-
Goldberg, M.1
Li, Y.P.2
Johanson, J.F.3
Mangel, A.W.4
Kitt, M.5
Beattie, D.T.6
-
36
-
-
33845656047
-
4 receptor agonist, ATI-7505, in humans
-
DOI 10.1111/j.1365-2982.2006.00865.x
-
M. Camilleri, M.I. Vazquez-Roque, D. Burton, T. Ford, S. McKinzie, and A.R. Zinsmeister Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans Neurogastroenterol Motil 19 1 2007 Jan 30 38 (Pubitemid 44952776)
-
(2007)
Neurogastroenterology and Motility
, vol.19
, Issue.1
, pp. 30-38
-
-
Camilleri, M.1
Vazquez-Roque, M.I.2
Burton, D.3
Ford, T.4
McKinzie, S.5
Zinsmeister, A.R.6
Druzgala, P.7
-
37
-
-
34147173976
-
Lubiprostone: A chloride channel activator
-
DOI 10.1097/01.mcg.0000225665.68920.df, PII 0000483620070400000003
-
B.E. Lacy, and L.C. Levy Lubiprostone: a chloride channel activator J Clin Gastroenterol 41 4 2007 Apr 345 351 (Pubitemid 46573059)
-
(2007)
Journal of Clinical Gastroenterology
, vol.41
, Issue.4
, pp. 345-351
-
-
Lacy, B.E.1
Campbell Levy, L.2
-
38
-
-
33645837674
-
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers
-
M. Camilleri, A.E. Bharucha, R. Ueno, D. Burton, G.M. Thomforde, and K. Baxter Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers Am J Physiol Gastrointest Liver Physiol 290 5 2006 May G942 G947
-
(2006)
Am J Physiol Gastrointest Liver Physiol
, vol.290
, Issue.5
-
-
Camilleri, M.1
Bharucha, A.E.2
Ueno, R.3
Burton, D.4
Thomforde, G.M.5
Baxter, K.6
-
39
-
-
37849024665
-
Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation
-
J.F. Johanson, D. Morton, J. Geenen, and R. Ueno Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation Am J Gastroenterol 103 1 2008 Jan 170 177
-
(2008)
Am J Gastroenterol
, vol.103
, Issue.1
, pp. 170-177
-
-
Johanson, J.F.1
Morton, D.2
Geenen, J.3
Ueno, R.4
-
40
-
-
77950347294
-
Efficacy and safety of lubiprostone in patients with chronic constipation
-
C.F. Barish, D. Drossman, J.F. Johanson, and R. Ueno Efficacy and safety of lubiprostone in patients with chronic constipation Dig Dis Sci 55 4 2010 Apr 1090 1097
-
(2010)
Dig Dis Sci
, vol.55
, Issue.4
, pp. 1090-1097
-
-
Barish, C.F.1
Drossman, D.2
Johanson, J.F.3
Ueno, R.4
-
41
-
-
58149103805
-
Clinical trial: Lubiprostone in patients with constipation-associated irritable bowel syndrome - Results of two randomized, placebo-controlled studies
-
D.A. Drossman, W.D. Chey, J.F. Johanson, R. Fass, C. Scott, and R. Panas Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies Aliment Pharmacol Ther 29 3 2009 Feb 1 329 341
-
(2009)
Aliment Pharmacol Ther
, vol.29
, Issue.3
, pp. 329-341
-
-
Drossman, D.A.1
Chey, W.D.2
Johanson, J.F.3
Fass, R.4
Scott, C.5
Panas, R.6
-
42
-
-
77249162216
-
Taking a lesson from microbial diarrheagenesis in the management of chronic constipation
-
A.E. Bharucha, and S.A. Waldman Taking a lesson from microbial diarrheagenesis in the management of chronic constipation Gastroenterology 138 3 2010 Mar 813 817
-
(2010)
Gastroenterology
, vol.138
, Issue.3
, pp. 813-817
-
-
Bharucha, A.E.1
Waldman, S.A.2
-
43
-
-
34548500315
-
Effect of 5 Days Linaclotide on Transit and Bowel Function in Females With Constipation-Predominant Irritable Bowel Syndrome
-
DOI 10.1053/j.gastro.2007.06.067, PII S0016508507012991
-
V. Andresen, M. Camilleri, I.A. Busciglio, A. Grudell, D. Burton, and S. McKinzie Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome Gastroenterology 133 3 2007 Sep 761 768 (Pubitemid 47374145)
-
(2007)
Gastroenterology
, vol.133
, Issue.3
, pp. 761-768
-
-
Andresen, V.1
Camilleri, M.2
Busciglio, I.A.3
Grudell, A.4
Burton, D.5
McKinzie, S.6
Foxx-Orenstein, A.7
Kurtz, C.B.8
Sharma, V.9
Johnston, J.M.10
Currie, M.G.11
Zinsmeister, A.R.12
-
44
-
-
77249122338
-
Efficacy of linaclotide for patients with chronic constipation
-
A.J. Lembo, C.B. Kurtz, J.E. Macdougall, B.J. Lavins, M.G. Currie, and D.A. Fitch Efficacy of linaclotide for patients with chronic constipation Gastroenterology 138 3 2010 Mar 886 895.e1
-
(2010)
Gastroenterology
, vol.138
, Issue.3
-
-
Lembo, A.J.1
Kurtz, C.B.2
MacDougall, J.E.3
Lavins, B.J.4
Currie, M.G.5
Fitch, D.A.6
-
45
-
-
77957895684
-
Efficacy and safety of once daily linaclotide administered orally for 12-Weeks in patients with chronic constipation: Results from 2 randomized, double-blind, placebo-controlled phase 3 trials
-
A. Lembo, H. Schneier, B.J. Lavins, S.J. Shiff, J.E. MacDougall, and X.D. Jia Efficacy and safety of once daily linaclotide administered orally for 12-Weeks in patients with chronic constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials Gastroenterology 139 2010 S53 S54 [abstract]
-
(2010)
Gastroenterology
, vol.139
-
-
Lembo, A.1
Schneier, H.2
Lavins, B.J.3
Shiff, S.J.4
MacDougall, J.E.5
Jia, X.D.6
-
46
-
-
50249107478
-
Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: Systematic review and meta-analysis of randomized controlled trials
-
E. McNicol, D.B. Boyce, R. Schumann, and D. Carr Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: systematic review and meta-analysis of randomized controlled trials Pain Med 9 6 2008 Sep 634 659
-
(2008)
Pain Med
, vol.9
, Issue.6
, pp. 634-659
-
-
McNicol, E.1
Boyce, D.B.2
Schumann, R.3
Carr, D.4
-
47
-
-
42649091132
-
Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study
-
DOI 10.1016/j.jpainsymman.2007.12.005, PII S0885392408000936
-
R.K. Portenoy, J. Thomas, M.L. Moeh Boatwright, D. Tran, F.L. Galasso, and N. Stambler Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study J Pain Symptom Manage 35 5 2008 May 458 468 (Pubitemid 351601995)
-
(2008)
Journal of Pain and Symptom Management
, vol.35
, Issue.5
, pp. 458-468
-
-
Portenoy, R.K.1
Thomas, J.2
Moehl Boatwright, M.L.3
Tran, D.4
Galasso, F.L.5
Stambler, N.6
Von Gunten, C.F.7
Israel, R.J.8
-
48
-
-
44349145194
-
Methylnaltrexone for opioid-induced constipation in advanced illness
-
DOI 10.1056/NEJMoa0707377
-
J. Thomas, S. Karver, G.A. Cooney, B.H. Chamberlain, C.K. Watt, and N.E. Slatkin Methylnaltrexone for opioid-induced constipation in advanced illness N Engl J Med 358 22 2008 May 29 2332 2343 (Pubitemid 351749157)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.22
, pp. 2332-2343
-
-
Thomas, J.1
Karver, S.2
Cooney, G.A.3
Chamberlain, B.H.4
Watt, C.K.5
Slatkin, N.E.6
Stambler, N.7
Kremer, A.B.8
Israel, R.J.9
-
50
-
-
45549109284
-
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
-
L. Webster, J.P. Jansen, J. Peppin, B. Lasko, G. Irving, and B. Morlion Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain Pain 137 2 2008 Jul 15 428 440
-
(2008)
Pain
, vol.137
, Issue.2
, pp. 428-440
-
-
Webster, L.1
Jansen, J.P.2
Peppin, J.3
Lasko, B.4
Irving, G.5
Morlion, B.6
-
51
-
-
20144366569
-
Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction - A 21-day treatment-randomized clinical trial
-
DOI 10.1016/j.jpain.2004.12.001
-
D.M. Paulson, D.T. Kennedy, R.A. Donovick, R.L. Carpenter, M. Cherubini, and L. Techner Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction - a 21-day treatment-randomized clinical trial J Pain 6 3 2005 Mar 184 192 (Pubitemid 40365022)
-
(2005)
Journal of Pain
, vol.6
, Issue.3
, pp. 184-192
-
-
Paulson, D.M.1
Kennedy, D.T.2
Donovick, R.A.3
Carpenter, R.L.4
Cherubini, M.5
Techner, L.6
Du, W.7
Ma, Y.8
Schmidt, W.K.9
Wallin, B.10
Jackson, D.11
-
52
-
-
23644447886
-
Effect of alvimopan and codeine on gastrointestinal transit: A randomized controlled study
-
DOI 10.1016/S1542-3565(05)00434-9, PII S1542356505004349
-
J. Gonenne, M. Camilleri, I. Ferber, D. Burton, K. Baxter, and K. Keyashian Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study Clin Gastroenterol Hepatol 3 8 2005 784 791 (Pubitemid 41116731)
-
(2005)
Clinical Gastroenterology and Hepatology
, vol.3
, Issue.8
, pp. 784-791
-
-
Gonenne, J.1
Camilleri, M.2
Ferber, I.3
Burton, D.4
Baxter, K.5
Keyashian, K.6
Foss, J.7
Wallin, B.8
Du, W.9
Zinsmeister, A.R.10
-
53
-
-
77956408794
-
The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health
-
B.S. Wong, A.S. Rao, M. Camilleri, N. Manabe, S. McKinzie, and I. Busciglio The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health Aliment Pharmacol Ther 32 7 2010 Oct 884 893
-
(2010)
Aliment Pharmacol Ther
, vol.32
, Issue.7
, pp. 884-893
-
-
Wong, B.S.1
Rao, A.S.2
Camilleri, M.3
Manabe, N.4
McKinzie, S.5
Busciglio, I.6
-
54
-
-
0034234832
-
Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans
-
B. Coulie, L.A. Szarka, M. Camilleri, D.D. Burton, S. McKinzie, and N. Stambler Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans Gastroenterology 119 1 2000 Jul 41 50 (Pubitemid 30452577)
-
(2000)
Gastroenterology
, vol.119
, Issue.1
, pp. 41-50
-
-
Coulie, B.1
Szarka, L.A.2
Camilleri, M.3
Burton, D.D.4
McKinzie, S.5
Stambler, N.6
Cedarbaum, J.M.7
-
55
-
-
0037973518
-
Neurotrophin-3 improves functional constipation
-
DOI 10.1111/j.1572-0241.2003.t01-1-07477.x
-
H.P. Parkman, S.S. Rao, J.C. Reynolds, L.R. Schiller, A. Wald, P.B. Miner Functional Constipation Study Investigators Neurotrophin-3 improves functional constipation Am J Gastroenterol 98 6 2003 Jun 1338 1347 (Pubitemid 36741532)
-
(2003)
American Journal of Gastroenterology
, vol.98
, Issue.6
, pp. 1338-1347
-
-
Parkman, H.P.1
Rao, S.S.C.2
Reynolds, J.C.3
Schiller, L.R.4
Wald, A.5
Miner, P.B.6
Lembo, A.J.7
Gordon, J.M.8
Drossman, D.A.9
Waltzman, L.10
Stambler, N.11
Cedarbaum, J.M.12
-
56
-
-
77649235471
-
Colchicine is effective for short-term treatment of slow transit constipation: A double-blind placebo-controlled clinical trial
-
S.A. Taghavi, S. Shabani, A. Mehramiri, A. Eshraghian, S.M. Kazemi, and M. Moeini Colchicine is effective for short-term treatment of slow transit constipation: a double-blind placebo-controlled clinical trial Int J Colorectal Dis 25 3 2010 Mar 389 394
-
(2010)
Int J Colorectal Dis
, vol.25
, Issue.3
, pp. 389-394
-
-
Taghavi, S.A.1
Shabani, S.2
Mehramiri, A.3
Eshraghian, A.4
Kazemi, S.M.5
Moeini, M.6
|